p66Shc mediates anoikis through RhoA by Ma, Zhenyi et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
JCB: REPORT
© The Rockefeller University Press    $30.00
The Journal of Cell Biology, Vol. 179, No. 1, October 8, 2007 23–31
http://www.jcb.org/cgi/doi/10.1083/jcb.200706097
JCB 23
Introduction
Parenchymal cells require integrin-dependent attachment to solid 
structures to survive. As a consequence of such anchorage depen-
dence, most tissue cells start to undergo apoptotic death within 
hours of being forced into suspension in a fl  uid environment, 
a process termed anoikis (Frisch and Francis, 1994). Physiological 
anoikis occurs during the involution of mammary and prostate 
glands, whereas pathological loss of anoikis is thought to accom-
pany the malignant cell’s acquisition of metastatic capabilities.
Presently, anoikis is understood largely in terms of with-
drawal of integrin-related outside-in survival signals. Thus, 
constitutive activation of the survival proteins focal adhesion 
kinase (FAK), Src, Akt, and Ras all bypass detachment-induced 
death (Frisch and Francis, 1994; Frisch et al., 1996; Martin et al., 
2006). However, anoikis can be circumvented in the absence 
of Ras, phosphoinositide 3-kinase, or FAK activation (McFall 
et al., 2001; Díaz-Montero et al., 2006; Kang et al., 2007), sug-
gesting that the activation of specifi  c death pathways may be 
necessary in addition to the disabling of survival signals. Further-
more, integrin ligation without structural matrix rigidity is in-
suffi  cient to prevent anoikis, indicating that integrins also control 
anoikis by sensing mechanical properties of the environment. 
Soluble matrix fragments or solid-phase RGD peptides bound 
to microbeads, e.g., ligate and cluster integrins, but neither pre-
vent rounding nor increase the survival rate of fl  oating endo-
thelial cells (Re et al., 1994), which is consistent with observations 
that cell rounding by itself forces death upon attachment-
  dependent cells (Chen et al., 1997).
The shortcomings of a unidirectional outside-in signaling 
model to explain attachment sensation is consistent with the con-
cept that cells initiate processes designed to gauge substrate stiff-
ness in an “inside-outside-in” feedback loop (Discher et al., 2005). 
The molecular machinery responsible for such mechanosensation 
and its relationship to anchorage dependence have remained 
recondite; hematopoietic cells, for instance, lack such machinery, 
as they are both anchorage independent and insensitive to sub-
strate stiffness (Discher et al., 2005). Interestingly, hematopoietic 
cells also repress expression of p66
Shc, the long isoform of the 
integrin-associated adaptor Shc (Migliaccio et al., 1997). Whereas 
p52
Shc is known to facilitate survival and proliferative signals, in 
large part through Ras recruitment and activation, p66
Shc is best 
known as a proapoptotic protein. Here, we show that p66
Shc per-
mits activation of RhoA, which leads to tension-dependent death 
in fl  oating cells. p66
Shc may thus be important in the efferent limb 
of a mechanosensory loop reporting detachment.
Results and discussion
p66
Shc mediates anoikis
p66
Shc is poorly expressed in fl  oating hematopoietic cell lines 
(Migliaccio et al., 1997), suggesting that either p66
Shc may 
mediate adhesion or that its repression may be important for 
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etachment of parenchymal cells from a solid ma-
trix switches contextual cues from survival to death 
during anoikis. Marked shape changes accom-
pany detachment and are thought to trigger cell death, 
although a working model to explain the coordination of 
attachment sensation, shape change, and cell fate is 
elusive. The constitutive form of the adapter Shc, p52
Shc, 
confers survival properties, whereas the longer p66
Shc signals 
death through association with cytochrome c. We ﬁ  nd 
that cells that lack p66
Shc display poorly formed focal 
adhesions and escape anoikis. However, reexpression of 
p66
Shc restores anoikis through a mechanism requiring 
focal adhesion targeting and RhoA activation but not an 
intact cytochrome c–binding motif. This pathway stimulates 
the formation of focal adhesions and stress ﬁ   bers in 
  attached cells and tension-dependent cell death upon 
detachment. p66
Shc may thus report attachment status to the 
cell by imposing a tension test across candidate anchorage 
points, with load failure indicating detachment.
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survival in suspension. We studied φNx-293 cells, as this epi-
thelioid line forms adherent cultures yet is relatively resistant to 
death while fl  oating. Indeed, these cells did not express p66
Shc 
even when grown as adherent monolayers, and suspension over 
low attachment plates for 16–24 h did not increase cell death 
(Fig. 1 A). In preliminary studies, transient reexpression of 
p66
Shc conferred sensitivity to anoikis in 293 cells. In contrast, 
overexpression of p52
Shc had a minimal effect on cell death in 
attached or fl  oating cells (Fig. 1 A). To avoid artifacts related 
to cell death from transfection itself, φNx-293 cells stably ex-
pressing Flag-p66
Shc (293-p66 cells) were studied. In agreement 
with transient transfection studies, stable expression of p66
Shc 
had no effect on cell death in adherent cells but caused death 
after detachment (Fig. 1 A). Cell death was accompanied by 
the activation of caspase 7, an executioner caspase activated 
during anoikis (Cardone et al., 1997; Bharadwaj et al., 2005), 
and the release of cytochrome c (Fig. S1, A and B, available at 
http://www.jcb.org/cgi/content/full/jcb.200706097/DC1). More 
specifi  cally, selective induction and mitochondrial localization 
of Bim has been shown to comprise a characteristic hallmark of 
anoikis (Reginato et al., 2003). Accordingly, detachment of p66
Shc-
expressing cells caused a marked induction of mitochondria-
associated Bim, without induction of Bax or Bid or suppression 
of Bcl-XL (Fig. 1 B).
As the phosphorylation of Ser36 has been shown to be 
necessary to cause apoptosis in response to oxidative stress 
(Migliaccio et al., 1999; Pinton et al., 2007), we introduced ei-
ther S36A or S36E mutations into p66
Shc and again created sta-
ble 293 lines. Surprisingly, the S36A mutant was able to confer 
anoikis, albeit not to the same magnitude as wild-type (wt) 
p66
Shc, whereas the phosphomimetic S36E mutation abrogated 
the anoikis-conferring property of p66
Shc (Fig. 1 A), consistent 
instead with a possible protective effect of S36 phosphorylation 
against anoikis. Indeed, phosphorylation of Ser36 was present 
in adherent 293-p66 cells that did not undergo cell death and did 
not occur in 293-p66 (S36A) cells undergoing anoikis (Fig. 1 C). 
Thus, Ser36 phosphorylation was neither necessary nor suf-
fi  cient for anoikis, suggesting a mechanism of cell death through 
p66
Shc different from that previously described for other stimuli 
(Migliaccio et al., 1999; Pinton et al., 2007). As further confi  r-
mation of the effects of p66
Shc and Ser36 on anoikis, we found 
that whereas vector-transfected 293 control cells were able to form 
colonies in soft agar, 293-p66 and 293-p66 (S36A) cells formed 
only abortive colonies (Fig. S1 C). In contrast, 293-p66 (S36E) 
cells, which escape anoikis, displayed prominent anchorage-
independent growth.
Because p66
Shc contains all the domains of the nonapop-
totic p52
Shc, it seemed unlikely that the former protein func-
tioned simply as a dominant-negative version of p52
Shc, unless 
the unique collagen homologous (CH) 2 N-terminal domain of 
p66
Shc masked other Shc domains through intra- or transmolecular 
interactions. We found, however, that neither Flag-p66
Shc nor 
the isolated Flag-CH2 domain coprecipitated with endogenous 
p66
Shc, p52
Shc, or the smaller p46
Shc (unpublished data). Indeed, 
transient expression of the CH2 domain decreased rather than 
increased anoikis (Fig. 1 D), which is consistent with a unique 
role for p66
Shc in causing anoikis.
We also studied nonimmortalized primary cells, human 
umbilical vein endothelial cells (HUVEC), based on their epi-
thelioid behavior and marked sensitivity to anoikis. As expected, 
HUVEC expressed substantial levels of p66
Shc and prominent 
detachment-induced cell death (Fig. 1 E) with the induction of 
Bim (Fig. S1 D). Knockdown of p66
Shc signifi  cantly decreased 
but did not eliminate anoikis. Although this incomplete pro-
tection may be caused by the partial effect of siRNA, death 
pathways independent of p66
Shc may exist. As with 293 cells, 
phosphorylation of Ser36 did not increase as HUVEC underwent 
anoikis (Fig. S1 E). Again supporting a specifi  c role for p66
Shc, 
transient expression of the isolated CH2 domain decreased 
anoikis by  33%, consistent with the transfection effi  ciency 
of HUVEC (Fig. 1 F).
Finally, sensitivity to anoikis is known to vary with the 
level of confl  uence in monolayers of nontransformed lines such 
as MDCK epithelial cells (Frisch and Francis, 1994). To inves-
tigate whether the endogenous regulation of p66
Shc might ac-
count for anoikis susceptibility within a given cell line, we 
correlated levels of p66
Shc with anoikis at sparse and confl  uent 
conditions. p66
Shc progressively increased with cell density, 
paralleling the increase in anoikis seen in confl  uent cells (Fig. 1 G). 
In contrast, the increase in p66
Shc in confl  uent cells did not cause 
cell death in attached MDCK cells. Notably, 3T3 cells, non-
transformed fi  broblastic cells known to undergo contact inhibi-
tion, also displayed increased p66
Shc protein expression and 
sensitivity to anoikis upon reaching confl  uence (Fig. 1 H). Thus, 
in endothelial, epithelial, and mesenchymal cells, both exter-
nally manipulated and endogenously regulated levels of p66
Shc 
determine sensitivity to anoikis.
Focal adhesion targeting by p66
Shc 
is associated with anoikis
Although the Shc proteins are known to associate with integrins, 
specifi  c integrin structures and binding mechanisms are not 
well understood. Focal adhesions are thought to function as 
predominant anchoring structures, so we investigated the target-
ing of GFP-fused p66
Shc to native HUVEC focal adhesions. 
Using total internal refl  ection fl  uorescence (TIRF) microscopy 
to image the ventral cell surface, we found that p66-GFP targeted 
well-formed zyxin-positive focal adhesions in HUVEC (Fig. 2 B). 
In parallel, transient expression of p66-GFP in 293 cells, which 
lack endogenous p66
Shc, conferred anoikis (Fig. 2 G). Focal ad-
hesion targeting was preserved in p52
Shc and did not occur with 
the isolated CH2 domain (Fig. 2, C and D). Association of Shc 
proteins with β1 integrins is known to occur indirectly through 
caveolin and Fyn through the Fyn Src homology (SH) 3 domain, 
presumably through proline-rich motifs contained within the 
p66
Shc CH1 domain (Wary et al., 1998). Disruption of either 
of two polyproline motifs within the CH1 domain (P411S/
P414S or P472S/P475S), however, had no effect on focal ad-
hesion targeting (Fig. S2, A and B, available at http://www.jcb
.org/cgi/content/full/jcb.200706097/DC1) and did not diminish 
p66
Shc-related anoikis (Fig. 2 G). Furthermore, deletion of the 
entire CH1 domain neither altered focal adhesion targeting nor 
diminished anoikis (Figs. 2 G and S2 C). This latter deletion 
also argues against the possibility that p66
Shc causes death by P66
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sequestering Grb2, which binds phosphotyrosine residues within 
the CH1 domain (Nicholson et al., 2001). Similarly, deletion of 
the C-terminal SH2 domain, known to bind growth factor recep-
tors, N-cadherin, and the β4 integrin subunit (Dans et al., 2001; 
Ravichandran, 2001), did not abrogate association with focal 
adhesions and did not decrease anoikis (Figs. 2 G and S2 D).
Deletion of the phosphotyrosine-binding (PTB) domain, 
however, caused complete loss of both focal adhesion targeting 
and anoikis activity (Fig. 2, E and G). Structural studies of 
this domain have revealed independent binding surfaces for 
phosphotyrosine-containing peptides and acidic phospholipids. 
We found that p66
Shc harboring a single R285Q mutation, which 
selectively disrupts the phosphotyrosine-anchoring pocket (Zhou 
et al., 1995), also delocalized p66
Shc from focal adhesions and 
completely lacked anoikis activity (Fig. 2, F and G). However, 
replacing the p66
Shc PTB domain with the focal adhesion target-
ing (FAT) domain of FAK, while restoring focal adhesion local-
ization, did not restitute anoikis (Figs. 2 G and S2 E). Thus the 
specifi  c molecular partner of p66
Shc within focal adhesions may 
determine its ability to relay detachment signals. The lack of 
Figure 1. p66
Shc confers anoikis. (A) 293 cells transiently transfected with pCINF-p52 or stably transfected with an empty vector, pCINF-p66 wt, pCINF-
p66 (S36A), or p66 (S36E) were left adherent or suspended for 16 h in low-attachment plates. Nuclear DNA fragmentation was assessed and demon-
strated increased cell death with detachment in cells expressing p66 (wt) or p66 (SA). (inset) Immunoblot for Shc showing p66
Shc, p52
Shc, and p46
Shc 
expression. *, P < 0.001 compared with attached control; †, P < 0.001 compared with p66 (wt) ﬂ  oating. (B) Stable transfectants of empty vector 
(293-vector) or p66
Shc (293-p66) were fractionated into mitochondrial or cytosolic content after 16 h of adherent or suspended culture and immunoblotted 
with the indicated antibodies. Bim was strongly induced and remained in the mitochondrial fraction with detachment. (C) 293 cells expressing either p66 wt or 
p66 (S36A) were immunoblotted after 16 h of suspension or adherence for phospho-S36 or total p66
Shc. (D) Stable p66
Shc cells were transiently transfected 
with either vector or the isolated Shc CH2 domain, and DNA fragmentation was measured after 16 h of adherence or suspension. (E) HUVEC were trans-
fected with either control siRNA or siRNA against the CH2 domain of Shc, and DNA fragmentation was assessed 16 h after suspension. (inset) Immunoblot 
for Shc with decreased p66
Shc expression. (F) HUVEC were transfected with a vector or CH2, and DNA fragmentation was measured after 16 h of suspension. 
(G) MDCK cells were plated at different densities and the next day left adherent or forced into suspension. DNA fragmentation at sparse and conﬂ  uent 
states was assessed. (inset) Immunoblot for Shc at the indicated levels of conﬂ  uence. (H) 3T3 cells were plated at different densities and anoikis was as-
sessed as in G. (inset) Immunoblot for Shc at the indicated levels of conﬂ  uence. (D–H) *, P < 0.001 compared with attached control; †, P < 0.001 compared 
with ﬂ  oating control. Error bars show mean ± SEM.JCB • VOLUME 179 • NUMBER 1 • 2007  26
Figure 2.  Focal adhesion targeting of p66
Shc is associated with anoikis. (A) Schematic of Shc with start positions of p66
Shc, p52
Shc, and p46
Shc shown. 
CH2, cytochrome c–binding (CCB), PTB, CH1, and SH2 domains are shown, with point mutations introduced. (B–F) HUVEC were cotransfected with GFP 
fusions of the indicated Shc mutations and DsRed-zyxin and imaged with TIRF microscopy. Focal adhesion targeting of p66
Shc-GFP was lost with deletion 
of the PTB domain or R285Q mutation. Bars, 10 μm. (G) 293 cells were transfected with the indicated Shc-GFP mutants and DNA fragmentation was mea-
sured 16 h after suspension or adherent culture. Error bars show mean ± SEM. P66
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effect of the PTB/FAT domain swap also suggests that p66
Shc 
does not simply compete with FAK for focal contact binding 
sites to diminish its survival. Indeed, p66
Shc had little effect on 
FAK (Y397) phosphorylation in 293 cells (Fig. S2 G). FAK 
(Y397) phosphorylation was low in 293-vector and 293-p66 
cells in both adherent and suspended states, suggesting that 
p66
Shc does not induce cell death by decreasing FAK autophos-
phorylation during detachment.
Finally, p66
Shc has recently been shown to translocate into 
the mitochondrial inner membrane, bind to cytochrome c directly, 
and undergo a redox cycle, causing oxidant-dependent permea-
bility transition and apoptosis in adherent cells undergoing apop-
tosis (Giorgio et al., 2005). Disruption of cytochrome c binding 
through mutation of Glu132/Glu133 completely disables the 
apoptotic activity of p66
Shc after oxidative stress or staurosporine 
(Giorgio et al., 2005; Pinton et al., 2007). We found, however, 
that p66 (E132Q and E133Q) remained localized to focal 
  adhesions and retained its full ability to cause anoikis (Figs. 2 G 
and S2 F). Together with the persistence of anoikis in the S36A 
mutant, these data suggest a unique mechanism for p66
Shc in 
mediating anoikis as opposed to other forms of apoptosis.
p66
Shc increases RhoA activation, causing 
cell death upon detachment
The targeting of p66
Shc and p52
Shc to focal adhesions is consis-
tent with observations that cells lacking functional Shc proteins 
display adhesion defects and alterations in focal contact and actin 
fi  ber organization (Lai and Pawson, 2000), and that integrins 
that nucleate focal adhesions also permit Shc-dependent prolif-
erative signals (Mettouchi et al., 2001). We questioned whether 
p66
Shc specifi  cally infl  uenced activation of RhoA, known to 
drive focal adhesion formation (Nobes and Hall, 1995). Using 
the rhotekin rho-binding domain (RBD) fused to GFP (RBD-
GFP) to report sites of RhoA activation, we again examined 
the ventral attachment surface of cells using TIRF microscopy. 
In control 293-vector cells, focal contacts identifi  ed by DsRed-
zyxin were small and peripheral, often taking the appearance of 
focal complexes, and cells were rounded with little evidence of 
RBD-GFP accumulation and only occasional actin stress fi  bers 
(Fig. 3, A and B). In contrast, 293-p66 cells were more spread 
with typical focal adhesions and more abundant stress fi  bers 
present. Numerous accumulations of RBD-GFP indicated focal 
activation of RhoA at ventral sites corresponding to zyxin-
containing contacts (Fig. 3, B and C). The infl  uence of p66
Shc on 
focal contact organization was also evident in HUVEC, which 
normally appear polarized with abundant focal adhesions and 
stress fi  bers. Knockdown of endogenous p66
Shc caused a gen-
eral loss of cell polarity with a substantial decrease in stress 
fi  bers and focal adhesions (Fig. 3, D and E).
Upon detachment, 293-vector cells displayed no activation 
of RhoA, whereas detachment of 293-p66 cells caused robust 
RhoA activation within 30 min (Fig. 4 A). 293-p66 (S36E) 
cells, being defective in anoikis, also failed to activate RhoA 
upon detachment. Dominant-negative RhoA (N19) or knock-
down  of endogenous RhoA both decreased p66
Shc-dependent 
anoikis, confi  rming a role for RhoA in detachment-induced death 
(Fig. 4, B and C). Conversely, active RhoA (V14) caused cell 
rounding (not depicted) and death in 293 cells lacking p66
Shc even 
while attached, and further augmented cell death while fl  oating 
(Fig. 4 D), suggesting a default decision of death by active RhoA 
in the absence of p66
Shc. In support of this, RhoA (V14) did not 
increase cell death in attached 293-p66 cells, whereas it increased 
cell death in fl  oating 293-p66 cells (Fig. 4 E). Thus p66
Shc not 
only initiates RhoA activation after detachment but appears to 
restrain RhoA-induced death in attached cells, in essence report-
ing appropriate anchorage through RhoA context. Again exam-
ining HUVEC as primary culture cells sensitive to anoikis, we 
found similar robust RhoA activation within 30 min of detach-
ment (Fig. 4 F). Antagonizing RhoA through either expression 
of RhoA (N19) or knockdown of endogenous RhoA suppressed 
anoikis, confi  rming a role for RhoA in this process in primary 
cells (Fig. 4, G and H).
Because RhoA is known to increase tension across at-
tachment sites with resultant focal adhesion and stress-fi  ber 
formation, we surmised that in fl  oating cells such tension would 
be applied against unanchored points, allowing a mechanical 
readout for detachment. Accordingly, antagonists of actino-
myosin contraction (myosin light chain kinase inhibitor ML-7; 
actin–myosin interaction inhibitor 2,3 butanedione monoxime 
[BDM]; and myosin II inhibitor (−)blebbistatin) decreased 
p66
Shc-dependent anoikis (Fig. 4 I), indicating a role for the 
generation of cytoskeletal tension in detachment sensing. 
Surprisingly, the Rho kinase inhibitor Y-27632 had only minimal 
effects on anoikis, suggesting a larger contribution of non-Rho 
kinase effectors.
Conclusions
Shc is best known as a transforming protein, acting to facili-
tate growth factor–dependent Ras activation through Grb2/Sos 
recruitment. However, growth factor receptors can directly bind 
Grb2 without Shc, suggesting that Shc dictates an additional level 
of control for this and perhaps other pathways. One possibility 
consistent with its scaffolding function is that it may link distal 
signaling with other transmembrane complexes, thus assigning 
environmental context to GTPase signals. For example, Shc may 
modify VEGF-receptor signaling in response to cell–cell con-
tact through its association with vascular endothelial–cadherin 
(Zanetti et al., 2002). In addition, Shc permits matrix-dependent 
EGF signaling to Ras and MAPKs (Moghal and Neel, 1998; Lai 
and Pawson, 2000) and, by association with specifi  c integrins, 
allows Rac1-dependent cell cycle progression after attachment 
to extracellular matrix proteins (Mettouchi et al., 2001).
Our data suggest that p66
Shc may follow this paradigm 
and report anchorage context through RhoA activation. Like 
Shc, RhoA is best known as a proliferative agent, at least in part 
working through Rho kinase–dependent increases in cytoskel-
etal tension (Pirone et al., 2006). Such RhoA-dependent ten-
sion is clearly coupled with the mechanical resistance offered 
by the cell’s environment, as epithelial cells grown in increas-
ingly stiff matrices acquire increasingly malignant phenotypes 
(Paszek et al., 2005). A similar RhoA-dependent test of matrix 
rigidity is used by mesenchymal stem cells to determine which 
differentiation program to initiate (McBeath et al., 2004; 
Engler et al., 2006). In the extreme case of detachment from a JCB • VOLUME 179 • NUMBER 1 • 2007  28
solid matrix, however, a liquid environment would be expected 
to provide no resistance to such tension, which would instead 
have to be borne entirely by internal struts such as microtubules. 
Notably, the anoikis-associated BH3-only protein Bim as-
sociates with microtubules and initiates apoptosis only upon 
its release from the cytoskeleton (Puthalakath et al., 1999). 
Figure 3. p66
Shc increases focal adhesions and stress ﬁ  bers. (A and B) 293-vector (top) or 293-p66 (bottom) cells were cotransfected with actin-GFP and 
DsRed-zyxin and imaged with TIRF microscopy. 293-p66 cells displayed more prominent actin stress ﬁ  bers and more developed focal adhesions than 
293-vector cells. (C) 293-vector (top) or 293-p66 (bottom) cells were cotransfected with DsRed-zyxin and RBD-GFP to mark sites of endogenous RhoA activation. 
Focal areas of RhoA activation were centered on DsRed-zyxin aggregates. (D and E) HUVEC were transfected with control or p66
Shc siRNA, actin-GFP, and 
DsRed-zyxin. Knockdown of p66
Shc generally diminished cell polarization and decreased actin stress ﬁ  bers and focal adhesions. *, P < 0.001 compared 
with control. Error bars show mean ± SEM. Bars, 10 μm.P66
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Although the mechanism by which unopposed tension causes 
death is as yet unclear, the situation may be similar to fi  broblasts 
grown in a stressed collagen matrix, which undergo apoptosis 
when the matrix is mechanically unloaded despite continued 
attachment to collagen (Grinnell et al., 1999). Another compa-
rable situation may occur in MDA-MD-231 breast cancer cells, 
in which overexpression of the motor protein tropomyosin-1 
  increases susceptibility to anoikis in a manner partially reversible 
by Y27632 (Bharadwaj et al., 2005).
Materials and methods
Plasmid construction
Human p66
Shc was PCR cloned from a previously constructed HUVEC 
library and subcloned into pCINF containing an N-terminal Flag tag 
to create pCINF-p66. S36A and S36E mutations were subsequently 
introduced into pCINF-p66 by PCR mutagenesis. The isolated CH2 domain 
and the remaining p52
Shc were subcloned into pCINF, and expression 
was assessed by immunoblot for the Flag tag. PCR strategies were used 
to subclone full-length p66
Shc, p52
Shc (residues 111–583 of p66
Shc), and 
the CH2 domain (residues 1–110) onto the N terminus of EGFP (pEGFP-
N3; CLONTECH Laboratories, Inc.). The P411S/P414S, P472S/P475S, 
E132Q/E133Q, and R285Q point mutations were each introduced into 
p66-GFP in single mutagenic PCR reactions. Starting with p66-GFP, do-
main deletions were accomplished by opposing PCR primers tailed with 
AgeI sites, resulting in deletions of the PTB (residues 119–317), CH1 (res-
idues 318–485), and SH2 (residues 486–584) domains. The p66-∆PTB 
plasmid was reopened with AgeI, and the FAT domain of FAK was ligated 
to create p66-PTB–FAT. The RBD of rhotekin was subcloned into pEGFP-N3 
to form RBD-GFP. DsRed-zyxin was a gift from A. Huttenlocher (University 
of Wiconsin, Madison, WI) and actin-GFP was obtained from CLONTECH 
Laboratories, Inc. RhoA (N19) and RhoA (V14) were obtained from the 
University of Missouri at Rolla cDNA Resource Center and subcloned 
into pCI-neo (Promega). Adenovirus-harboring RhoA (N19) was a gift of 
C. Chen (University of Pennsylvania, Philadelphia, PA). New constructs 
were conﬁ  rmed by sequencing.
Figure 4. p66
Shc increases RhoA activation, leading to anoikis. (A) 293-vector, 293-p66, or 293-p66 (S36E) cells were forced into suspension and har-
vested at the indicated times. RhoA activation was assessed by RBD pulldown. Expression of p66 (wt) but not p66 (S36E) increased RhoA activation within 
30 min of suspension. 293-p66 cells were transfected with control or RhoA siRNA (B), or control or RhoA (N19; C), and DNA fragmentation was measured 
16 h after suspension. 293-vector (D) or 293-p66 (E) cells were transfected with a vector or RhoA (V14), and DNA fragmentation was measured after 16 h 
in suspension. (F) HUVEC were suspended for the indicated times and RhoA activity was assessed by RBD pulldown. (G) HUVEC were transfected with 
control or RhoA siRNA, and DNA fragmentation was measured after 16 h of suspension. (inset) Immunoblot for RhoA. (H) HUVEC were infected with 
Ad-lacZ control virus or Ad-RhoA (N19), and DNA fragmentation was assessed 16 h after suspension. (I) 293-p66 cells were suspended for 8 h in the presence 
of 50 μM ML-7, 10 mM BDM, 1 μM (−)blebbistatin, or 10 μM Y-27632. *, P < 0.001 compared with adherent control; †, P < 0.001 compared with 
ﬂ  oating control. Error bars show mean ± SEM.JCB • VOLUME 179 • NUMBER 1 • 2007  30
Cell culture
φNx-293 cells were obtained from American Type Culture Collection with 
permission from G. Nolan (Stanford University, Stanford, CA). MDCK and 
NIH 3T3 cells were also obtained from American Type Culture Collection. 
Stable transfectants of 293 cells with pCINF, pCINF-p66, pCINF-p66 (S36A), 
or pCINF-p66 (S36E) were selected with G418. Single cell clones were 
tested for comparable expression of p66
Shc between mutants and relative to 
p52
Shc. Mixed clones, particularly of 293-p66, progressively lost expres-
sion of p66
Shc and thus were not used. G418 was removed for at least two 
passages before anoikis studies. HUVEC (Clonetics) were used at passages 
four and ﬁ  ve.
Reagents
The following antibodies were used: Shc, Bim, Bid, Bak, BclXL (BD Bio-
sciences); p66
Shc (pS36; Qbiogene); Bax, RhoA, cleaved caspase 7 
(Cell Signaling Technology); cytochrome c (MitoSciences); FAK (Santa Cruz 
Biotechnology, Inc.); FAK (pY397; Zymed Laboratories); and actin (Millipore). 
ML-7, BDM, and (−)blebbistatin were obtained from Sigma-Aldrich, and 
Y-27632 was obtained from Calbiochem.
Cell death assays
Cells were plated on either cell culture–treated or low-attachment 24-well 
plates (Corning Inc.). DNA fragmentation was assessed using the cell 
death ELISA (Roche). Mitochondrial release of cytochrome c was assessed 
by digitonin permeabilization. Preliminary titration studies were performed 
in 293 cells to determine optimal digitonin concentrations for selective 
plasma membrane permeabilization. Cells were washed and permeabi-
lized in 10 ng/ml digitonin in sucrose buffer on ice for 10 min. Mitochon-
dria were harvested by centrifugation at 1,000 g for 5 min. Fractions were 
then immunoblotted for cytochrome c. Activated caspase 7 was assessed 
with antisera speciﬁ  c for cleaved caspase. Induction of BH domain pro-
teins was assessed by fractionating cells into mitochondrial and cytosolic 
fractions and immunoblotting for BclXL, Bax, Bid, and Bim. Anchorage-
independent growth was assessed by plating cells in 0.35% agar on a bed 
of 0.9% agar in DME with 10% fetal calf serum at a density of 2,000 cells/ml. 
Visible colonies were scored after 14 d.
Transfection and knockdown
HUVEC were electroporated with expression constructs 6–8 h after release 
from thymidine-induced G1 arrest as described previously (Wu et al., 
2005). 293 cells were electroporated unsynchronized. Control cells were 
transfected with empty pCI-neo or pCINF. siRNA against the CH2 domain 
of p66
Shc (nt 42–60), RhoA (nt 355–375), and the negative control luciferase 
were obtained from Dharmacon. Transfection of siRNA was accomplished 
with TransIT-TKO (Mirus). Adenoviral infection of HUVEC was performed at 
an MOI of 1:100, titrated to protein expression. Control cells were infected 
with the same titer of Ad-lacZ.
Microscopy
After transfection, cells were plated on ﬁ  bronectin-coated chambered cover-
slips and observed live in full media without ﬁ  xation 24–48 h later. TIRF 
microscopy was performed using a TE2000-U system (Nikon). Sequential 
red and green channels were acquired at 37°C through a 60×/NA 1.45 
oil-immersion objective (Nikon) with a digital camera (Coolsnap ES; Roper) 
using Metamorph software (Molecular Devices). Morphological features 
were scored by examining all cells in at least ﬁ  ve high-power ﬁ  elds per 
chamber in at least four chambers.
RhoA activity
RhoA GTP loading was assessed by a pulldown technique (Wu et al., 
2005). The RBD of mouse rhotekin (residues 7–89) was previously ligated 
into pGEX-2TK (Wu et al., 2005), and recombinant proteins were puriﬁ  ed 
with GSH-sepharose (GE Healthcare). Active GTP-loaded Rho proteins 
from the 10,000-g supernatant of cell lysate were pulled down and immuno-
blotted with antisera for RhoA.
Online supplemental material
Fig. S1 shows that p66
Shc increases caspase 7 cleavage and cytochrome c 
release, decreases anchorage-independent growth in 293 cells, and in-
creases Bim in suspended HUVEC. Fig. S2 shows that p66 (P411S and 
P414S), p66 (P472S and P475S), p66 (∆CH1), p66 (∆SH2), p66 (FAT-PTB), 
and p66 (E132Q and E133Q) display persistent focal adhesion targeting, 
and that p66
Shc does not affect FAK (Y397) phosphorylation. Online sup-
plemental material is available at http://www.jcb.org/cgi/content/full/
jcb.200706097/DC1.
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